Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
Clinical trial NCT01442168 · TERMINATED
Trial details
- NCT number
- NCT01442168
- Sponsor
- Modus Therapeutics AB
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.